|
|||||
|
|
Needle-Free Subcutaneous Sumatriptan (Sumavel™ DosePro™): Bioequivalence and Ease of Use |
|
| Authors: | Jan Lewis Brandes, Roger K. Cady, Fred G. Freitag, Timothy R. Smith, Patricia Chandler, Anthony W. Fox, Lawrence Linn, Stephen J. Farr |
| Affiliation: | From the Nashville Neuroscience Group, Nashville, TN, USA (J.L. Brandes);Headache Care Center, Springfield, MO, USA (R.K. Cady);Diamond Headache Clinic, Chicago, IL, USA (F.G. Freitag);Mercy Health Research –Ryan Headache Center, St Louis, MO, USA (T.R. Smith);Covance Inc –Clinical Pharmacology, Dallas, TX, USA (P. Chandler);EBD Group –Research, Carlsbad, CA, USA (A. Fox);Zogenix Inc –Clinical Research, San Diego, CA, USA (L. Linn and S.J. Farr) |
| Abstract: | |
| Keywords: | sumatriptan subcutaneous needle-free administration pharmacokinetic bioequivalence clinical utility |